|By PR Newswire||
|August 18, 2014 04:39 PM EDT||
WASHINGTON, Aug. 18, 2014 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) President & CEO, Laurie Fenton Ambrose praised the National Cancer Institute's (NCI) new trial, launched today, that will focus on the prevention of recurrence in two specific types of lung cancers when they are caught at early stage and surgically removed.
"This trial demonstrates the power of CT screening to open new research windows on critical problems, such as recurrence, that have eluded solutions to date," she said.
Few trials have been conducted on earlier stage lung cancer because so few lung cancer patients have been diagnosed at early stage. With wider availability of low dose CT, this will change.
This trial, the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, will test whether erlotinib and crizotinib, already approved as targeted therapies for EGFR positive and ALK positive types of late stage lung cancer, can effectively block recurrence when those cancers are found at an earlier stage.
Since the EGFR and ALK mutations are found in just 5% to 10% of lung cancers, NCI estimates that the tumors from 6,000 to 8,000 post-surgical patients would have to be tested for the mutations to yield about 600 patients eligible for the trial.
Patients whose resected tumors test positive will be given adjuvant chemotherapy and possibly radiation, and then treated with either erlotinib or crizotinib and followed for five years for recurrence.
"In this new era of CT screening for lung cancer, the number of lung cancers found at early stage will increase dramatically, making trials and new lifesaving breakthroughs like this feasible," Fenton Ambrose said.
Lung Cancer Alliance, www.lungcanceralliance.org, is the leading national organization providing hope for the lung cancer community by offering patient support, national awareness, community outreach, and advocacy to advance research into early detection and treatments for all forms of lung cancer.
For more details on the trial please go to: http://www.cancer.gov/newscenter/newsfromnci/2014/ALCHEMISTlaunchQandA.
SOURCE Lung Cancer Alliance
Mar. 24, 2017 01:30 PM EDT Reads: 1,486
Mar. 24, 2017 01:15 PM EDT Reads: 3,767
Mar. 24, 2017 01:15 PM EDT Reads: 358
Mar. 24, 2017 12:45 PM EDT Reads: 219
Mar. 24, 2017 12:45 PM EDT Reads: 1,799
Mar. 24, 2017 12:30 PM EDT Reads: 2,939
Mar. 24, 2017 12:15 PM EDT Reads: 1,317
Mar. 24, 2017 12:15 PM EDT Reads: 872
Mar. 24, 2017 12:00 PM EDT Reads: 1,812
Mar. 24, 2017 12:00 PM EDT Reads: 1,571
Mar. 24, 2017 11:30 AM EDT Reads: 3,271
Mar. 24, 2017 10:55 AM EDT Reads: 355
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Mar. 24, 2017 10:45 AM EDT Reads: 1,342
In today's enterprise, digital transformation represents organizational change even more so than technology change, as customer preferences and behavior drive end-to-end transformation across lines of business as well as IT. To capitalize on the ubiquitous disruption driving this transformation, companies must be able to innovate at an increasingly rapid pace. Traditional approaches for driving innovation are now woefully inadequate for keeping up with the breadth of disruption and change facing...
Mar. 24, 2017 10:45 AM EDT Reads: 10,565
SYS-CON Events announced today that Infranics will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Since 2000, Infranics has developed SysMaster Suite, which is required for the stable and efficient management of ICT infrastructure. The ICT management solution developed and provided by Infranics continues to add intelligence to the ICT infrastructure through the IMC (Infra Management Cycle) based on mathemat...
Mar. 24, 2017 09:45 AM EDT Reads: 2,679